The mTOR signaling pathway as a treatment target for intracranial neoplasms

Keyphrases

• Mammalian Target of Rapamycin (mTOR) 100%
• Targeted Treatment 100%
• Brain Tumor 100%
• MTOR Inhibitor 100%
• Mammalian Target of Rapamycin Signaling Pathway 100%
• Intracranial Neoplasm 100%
• Cancer Therapy 50%
• Clinical Trials 50%
• Tumor Growth 50%
• Hyperactivity 50%
• Epithelial Neoplasm 50%
• Human Cancer 50%
• New Humanities 50%
• Human Brain Tumor 50%
• Syndromic 50%
• Tumor Pathogenesis 50%

Medicine and Dentistry

• Cell Signaling Pathway 100%
• Mechanistic Target of Rapamycin 100%
• Intracranial Tumor 100%
• Mammalian Target of Rapamycin Inhibitor 40%
• Cancer Therapy 20%
• Neoplasm 20%
• Clinical Trial 20%
• Hyperactivation 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Mammalian Target of Rapamycin 100%
• Intracranial Tumor 100%
• Mammalian Target of Rapamycin Inhibitor 40%
• Neoplasm 20%
• Clinical Trial 20%
• Malignant Neoplasm 20%